Targeted imaging and therapy of brain cancer using theranostic nanoparticles

Area of Science:

• Oncology
• Nanomedicine
• Biotechnology

Background:

• Despite advances in brain cancer research, mortality rates remain stagnant over three decades.
• Novel diagnostic and therapeutic strategies are crucial for improving patient outcomes.
• Nanotheranostic platforms present a promising avenue for integrated cancer imaging and treatment.

Purpose of the Study:

• To review the application of advanced theranostic nanoparticles for targeted brain cancer imaging.
• To explore the potential of nanovehicles in revolutionizing brain cancer treatment strategies.

Main Methods:

• Discussion of recent developments in nanomedicine for oncology.
• Review of theranostic nanoparticle functionalities for targeted drug delivery and imaging.
• Analysis of advantages over conventional cancer therapeutic agents.

Main Results:

• Nanotheranostic platforms enable targeted delivery to tumor sites, minimizing systemic toxicity.
• These platforms can enhance the pharmacokinetics of hydrophobic or labile drugs.
• Multifunctional nanovehicles offer potential for simultaneous imaging, treatment, and therapeutic response prediction.

Conclusions:

• Theranostic nanoparticles represent a significant advancement in brain cancer diagnostics and therapeutics.
• Their multifunctionality and targeted approach hold promise for paradigm-shifting brain cancer care.
• Further research into nanotheranostic applications is essential for clinical translation.